scholarly article | Q13442814 |
P50 | author | Yung-Jue Bang | Q16180903 |
Eui Kyu Chie | Q44335316 | ||
Seock-Ah Im | Q58821370 | ||
Kyubo Kim | Q87569611 | ||
Do-Youn Oh | Q87569618 | ||
Tae-You Kim | Q87569625 | ||
Kyung Hun Lee | Q87845591 | ||
Sae-Won Han | Q91404079 | ||
Younak Choi | Q117206995 | ||
P2093 | author name string | Tae-Yong Kim | |
Sung Whan Ha | |||
P2860 | cites work | Analysis of mortality rates for pancreatic cancer across the world | Q24646766 |
Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study | Q33349410 | ||
Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: a single-institution retrospective analysis | Q34518978 | ||
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial | Q36476666 | ||
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. | Q36751555 | ||
A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer | Q36792356 | ||
Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer--a multi-centre ra | Q37457763 | ||
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? | Q43960823 | ||
Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction | Q44908374 | ||
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of | Q46604466 | ||
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. | Q46608868 | ||
Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology | Q48766509 | ||
Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies | Q57758319 | ||
Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group | Q69919858 | ||
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study | Q70062032 | ||
Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study | Q70937645 | ||
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy | Q80407725 | ||
Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis | Q84100587 | ||
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial | Q86800667 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P921 | main subject | chemoradiotherapy | Q5090613 |
pancreatic cancer | Q212961 | ||
chemotherapy | Q974135 | ||
P304 | page(s) | 1045-1055 | |
P577 | publication date | 2015-10-16 | |
P1433 | published in | Cancer Research and Treatment | Q18411021 |
P1476 | title | Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study | |
P478 | volume | 48 |
Q38801235 | Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy |
Q40506490 | Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma |
Q33868592 | Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study |
Q91771819 | Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer |
Search more.